During COVID-19 vaccine rollouts social media has been a breeding ground for anti-vaccine sentiments, which have led to vaccine hesitancy. This can increase vaccine-preventable diseases and create public health crises.
Health-related misinformation in social media has been shown to lead to poor health outcomes, including delayed treatment, unnecessary treatment, and wrong treatment. False information can spread rapidly: Social media platforms allow information to be shared quickly and widely, which means that false information can spread rapidly. This can result in a large number of people being exposed to incorrect information and acting on it, which can have serious consequences.
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
With this in mind, recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Now the Director of Infectious Diseases at Mater Health, Paul talks about coming into the field of infectious disease clinical trials, starting in malaria to now focusing on influenza, RSV and COVID-19 vaccines.
Paul reflects on the opportunity to learn and be involved in clinical trials from an early career stage and a turning point being in a senior role for a Phase 1 clinical study.
On the topic of misinformation in public health perception and literacy, Paul sees the issue continuing to circulate on the purpose of vaccines in general. This has also created hesitancy in ‘routine’ vaccine uptake.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
Whilst the past 5 years may have improved public health literacy, it’s been outweighed by significant misinformation that does require an active campaign to encourage people to seek out information from reputable sources.
In closing, Paul talks about his advice for anyone looking to enter the field of clinical trials and vaccines: Early on, take the opportunities that arise, to be involved, help increase experience and new learning.
You Might also like
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
-
Nurse recognised for reducing hospital waste
A nurse who started a charity from a granny flat in her parent’s backyard to reduce hospital waste has taken out one of the Australian nursing profession’s most prestigious honours.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.